H.C. Wainwright lowered the firm’s price target on Arvinas (ARVN) to $81 from $87 and keeps a Buy rating on the shares. Given the company’s ...
H.C. Wainwright raised the firm’s price target on Coinbase (COIN) to $330 from $255 and keeps a Buy rating on the shares. President Donald ...
D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at ...
Investment analysts at HC Wainwright lowered their FY2028 earnings estimates for X4 Pharmaceuticals in a research note issued on Friday, February 7th. HC Wainwright analyst S. Ramakanth now forecasts ...
H.C. Wainwright analyst Mike Colonnese increased the price target for Coinbase Global Inc. (NASDAQ:COIN) shares to $330, up from the previous $255, while maintaining a Buy rating on the stock. The ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
CEO Dikla Czaczkes Akselbrad highlighted the recommendation by the independent Data Safety Monitoring Board (DSMB) to conclude the SHIELD II Phase 3 trial for D-PLEX100 upon the enrollment of 800 ...
Management lowered fiscal 2025 revenue guidance to $77M to $83M, reflecting timing changes in large projects. For Q4 2025, revenue is expected to range between $19M and $25M. Jenkins shared confidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results